A Proposal from the Montpellier World Health Organization Collaborating Centre for Better Management and Prevention of Anaphylaxis

Archive ouverte

Tanno, Luciana Kase | Touati, Nidhal | Allichon, Salome | Martin, Bryan | Ebisawa, Motohiro | Ansotegui, Ignacio | Sanchez-Borges, Mario | Cardona, Victoria | Greenberger, Paul | Ryan, Dermot | Pouessel, Guillaume | Beaudouin, Etienne | Renaudin, Jean-Marie | Thien, Francis | Chang, Yoon-Seok | Pawankar, Ruby | Gomez, Maximiliano | Jares, Edgardo | Staffeld, Patricia Latour | Agache, Ioana | Muraro, Antonella | Mahr, Todd | Sublett, James | Casale, Thomas | Lang, David | Demoly, Pascal

Edité par CCSD ; Elsevier / American Academy of Allergy, Asthma & Immunology / American Academy of Allergy, Asthma and Immunology -

International audience. Since the first description of anaphylaxis in 1902, its clinical importance as an emergency condition has been recognized worldwide. Anaphylaxis is a severe, potentially life-threatening systemic hypersensitivity reaction characterized by rapid onset and the potential to endanger life through respiratory or circulatory compromise. It is usually, although not always, associated with skin and mucosal changes. Although the academic/scientific communities have advocated to promote greater awareness and protocols for the management of anaphylaxis based on best evidence, there are few efforts documenting feedback as to the success of these efforts. In this article, we review the key unmet needs related to the diagnosis and management of anaphylaxis, and propose a public health initiative for prevention measures and a timetable action plan that intends to strengthen the collaboration among health professionals and especially primary care physicians dealing with anaphylaxis, which can encourage enhanced quality of care of patients with anaphylaxis. More than calling for a harmonized action for the best management of anaphylaxis to prevent undue morbidity and mortality, the Montpellier World Health Organization Collaborating Centre here proposes an action plan as a baseline for a global initiative against anaphylaxis. We strongly believe that these collaborative efforts are a strong public health and societal priority that is consistent with the overarching goals of providing optimal care of allergic patients and best practices of allergology.

Suggestions

Du même auteur

Biologic Agents for the Treatment of Anaphylaxis

Archive ouverte | Tanno, Luciana Kase | CCSD

International audience. Several biologic therapies and new devices are emerging as potential preventive treatment of anaphylaxis. However, adrenaline (epinephrine) is still the first-line treatment of any type of an...

Allergy in the World Health Organization's International Classification of Diseases (ICD)‐11

Archive ouverte | Tanno, Luciana Kase | CCSD

International audience. The International Classification of Diseases (ICD) provides a common language for use worldwide as a diagnostic and classification tool for epidemiology, clinical purposes, and health managem...

Anaphylaxis in children

Archive ouverte | Tanno, Luciana Kase | CCSD

International audience. Anaphylaxis in children is a potential acute life-threatening systemic hypersensitivity reaction. Anaphylaxis fatality rate is estimated to be 0.65% to 2%. Food is the main anaphylaxis trigge...

Chargement des enrichissements...